(Press-News.org) Newborn babies' immune system development and levels of vitamin D have been found to vary according to their month of birth, according to new research.
The research, from scientists at Queen Mary, University of London and the University of Oxford, provides a potential biological basis as to why an individual's risk of developing the neurological condition multiple sclerosis (MS) is influenced by their month of birth. It also supports the need for further research into the potential benefits of vitamin D supplementation during pregnancy.
Around 100,000 people in the UK have MS, a disabling neurological condition which results from the body's own immune system damaging the central nervous system. This interferes with the transmission of messages between the brain and other parts of the body and leads to problems with vision, muscle control, hearing and memory.
The development of MS is believed to be a result of a complex interaction between genes and the environment.
A number of population studies have suggested that the month you are born in can influence your risk of developing MS. This 'month of birth' effect is particularly evident in England, where the risk of MS peaks in individuals born in May and drops in those delivered in November. As vitamin D is formed by the skin when it is exposed to sunlight, the 'month of birth' effect has been interpreted as evidence of a prenatal role for vitamin D in MS risk.
In this study, samples of cord blood – blood extracted from a newborn baby's umbilical cord – were taken from 50 babies born in November and 50 born in May between 2009 and 2010 in London.
The blood was analysed to measure levels of vitamin D and levels of autoreactive T-cells. T-cells are white blood cells which play a crucial role in the body's immune response by identifying and destroying infectious agents, such as viruses. However some T-cells are 'autoreactive' and capable of attacking the body's own cells, triggering autoimmune diseases, and should be eliminated by the immune system during its development. This job of processing T-cells is carried out by the thymus , a specialised organ in the immune system located in the upper chest cavity.
The results showed that the May babies had significantly lower levels of vitamin D (around 20 per cent lower than those born in November) and significantly higher levels (approximately double) of these potentially harmful autoreactive T-cells, compared to the sample of November babies.
Co-author Dr Sreeram Ramagopalan, a lecturer in neuroscience at Barts and The London School of Medicine and Dentistry, part of Queen Mary, said: "By showing that month of birth has a measurable impact on in utero immune system development, this study provides a potential biological explanation for the widely observed "month of birth" effect in MS. Higher levels of autoreactive T-cells, which have the ability to turn on the body, could explain why babies born in May are at a higher risk of developing MS.
"The correlation with vitamin D suggests this could be the driver of this effect. There is a need for long-term studies to assess the effect of vitamin D supplementation in pregnant women and the subsequent impact on immune system development and risk of MS and other autoimmune diseases."
###
The research letter is published today in the journal JAMA Neurology.
Month of birth impacts on immune system development
2013-04-09
ELSE PRESS RELEASES FROM THIS DATE:
Study finds key to calling back-up help when tumor-fighter p53 goes down
2013-04-09
WASHINGTON, D.C. – Tumor suppression, the family business of the sibling genes p53, p63 and p73, is undermined from within by the split personalities of p63 and p73, which each produce protein forms that not only block the work of the other two genes but also shut down its own cancer-stifling fraternal twin.
In a presentation at the AACR Annual Meeting 2013, scientists from The University of Texas MD Anderson Cancer Center demonstrate that tumor suppression can be restored in mice that lack p53 by knocking out the ∆N isoforms of p63 and p73 that interfere with tumor ...
AACR news: XL-184 (Cabozantinib) goes 12-for-12 in colorectal cancer explants
2013-04-09
The novel c-MET and VEGFR2 inhibitor, XL-184 (Cabozantinib), resulted in a significant decrease in tumor growth in 12 out of 12 colorectal cancer (CRC) patient-derived explants, with 8 of the explants exhibiting stable disease. The results of this preclinical work are presented at the AACR Annual Meeting 2013.
"With molecularly targeted agents, we typically see 3 or 4 CRC explant models with a significant decrease in tumor growth. Here we have a drug that was active in every explant we tested. It's really exciting," says John Arcaroli, PhD, investigator at the University ...
AACR news: Autophagy-addicted breast cancers killed by anti-malaria drug, chloroquine
2013-04-09
The process of autophagy cleans cells – they wrap up the bad stuff and then dispose of it. And so it stands to reason that inhibiting autophagy would make cancer cells less able to cleanse themselves of chemotherapy and so more susceptible to the drugs. That's what the traditional anti-malaria drug, chloroquine, does – it inhibits autophagy. Existing clinical trials are testing chloroquine/chemotherapy combinations against breast cancer.
Research presented at the AACR Annual Meeting 2013 shows that some breast cancer subtypes depend on autophagy more than others – and ...
Possible predictive biomarker for patients who may respond to autophagy inhibitors
2013-04-09
WASHINGTON, DC – Autophagy, the process by which cells that are starved for food resort to chewing up their own damaged proteins and membranes and recycling them into fuel, has emerged as a key pathway that cancer cells use to survive in the face of assault by chemotherapy and radiation. Using drugs to shut down that survival mechanism shows great promise, especially when combined with targeted agents and standard chemotherapies, but until recently, it has been unclear which patients' cancers would respond to that combination therapy.
A team led by researchers from the ...
Surface diffusion plays a key role in defining the shapes of catalytic nanoparticles
2013-04-09
Controlling the shapes of nanometer-sized catalytic and electrocatalytic particles made from noble metals such as platinum and palladium may be more complicated than previously thought.
Using systematic experiments, researchers have investigated how surface diffusion – a process in which atoms move from one site to another on nanoscale surfaces – affects the final shape of the particles. The issue is important for a wide range of applications that use specific shapes to optimize the activity and selectivity of nanoparticles, including catalytic converters, fuel cell ...
Thinking you're old and frail
2013-04-09
Older adults who categorise themselves as old and frail encourage attitudinal and behavioural confirmation of that identity.
This is the conclusion of a study conducted by Krystal Warmoth and colleagues at University of Exeter Medical School, which is being presented today, 9th April 2013, at the British Psychological Society Annual Conference in Harrogate, UK.
Krystal Warmoth interviewed 29 older adults in the South West of England face-to-face. Interviews conducted asked about their experiences of ageing and frailty. Self-perception and identification related to ...
Particles changing angle: Unexpected orientation in capillaries
2013-04-09
When small particles flow through thin capillaries, they display an unusual orientation behaviour. This has recently been discovered by a research team led by Prof. Stephan Förster and Prof. Walter Zimmermann (University of Bayreuth, Germany) at the X-ray sources DORIS III and PETRA III of the research centre DESY in Hamburg, Germany. The discovery is of major importance for spinning processes designed for the production of synthetic fibres, and for the understanding of vascular stenosis. The scientists of Bayreuth University, the Radboud University Nijmegen (Netherlands), ...
Moving cells with light holds medical promise
2013-04-09
Scientists at Washington University School of Medicine in St. Louis have shown they can coax cells to move toward a beam of light. The feat is a first step toward manipulating cells to control insulin secretion or heart rate using light.
Their research is published April 8 in the Proceedings of the National Academy of Sciences Online Early Edition.
"We have succeeded in using light as a kind of on-off switch to control cells' behavior," says principal investigator N. Gautam, PhD, a professor of anesthesiology. "Much of the way cells behave is due to their ability to ...
University of Tennessee professor's research shows Gulf of Mexico resilient after spill
2013-04-09
The Gulf of Mexico may have a much greater natural ability to self-clean oil spills than previously believed, according to Terry Hazen, University of Tennessee-Oak Ridge National Laboratory Governor's Chair for Environmental Biotechnology.
The bioremediation expert presented his Deepwater Horizon disaster research findings at the 245th National Meeting and Exposition of the American Chemical Society (ACS), the world's largest scientific society.
Hazen conducted research following the 2010 Deepwater Horizon disaster, which is estimated to have spilled 210 million gallons ...
A hijacking of healthy cellular circuits
2013-04-09
April 8, 2013, New York, NY and San Diego Calif. – Proteins that control cell growth are often mutated in cancer, and their aberrant signaling drives the wild proliferation of cells that gives rise to tumors. One such protein, the epidermal growth factor receptor (EGFR), fuels a wide variety of cancers—including a highly malignant brain cancer known as glioblastoma. Yet drugs devised to block its signaling tend to work only for a short while, until the cancer cells adapt to evade the therapy. So far, much of the research examining such drug resistance has focused on how ...